Self-contained, self-piercing, side-expelling marking apparatus

Information

  • Patent Grant
  • 10813716
  • Patent Number
    10,813,716
  • Date Filed
    Friday, December 22, 2017
    7 years ago
  • Date Issued
    Tuesday, October 27, 2020
    4 years ago
Abstract
A method of operating a tissue marking apparatus includes providing a tissue marking apparatus having a cannula, a stylet, and an imaging marker, the cannula having a peripheral wall forming a lumen and a lateral opening in the peripheral wall that is open to the lumen, and having a resilient end wall extending downwardly from the peripheral wall at a distal extent of the lateral opening, the stylet being slidably received within the lumen of the cannula for movement in the lumen; moving the stylet in a distal direction to expel the imaging marker from the lateral opening; and continue moving the stylet in the distal direction to deflect the resilient end wall of the cannula such that a distal end of the stylet passes beneath the resilient end wall to substantially close off the lateral opening of the cannula.
Description
BACKGROUND OF THE INVENTION
Field of the Invention

This invention relates generally to an apparatus for the percutaneous positioning of an imaging marker for identifying the location of a lesion in a biopsy procedure. More particularly, the invention relates to a self-contained marking apparatus that expels the imaging marker through the side of the marking device.


Description of the Related Art

Tissue biopsies are commonly performed on many areas and organs of the body where it is desirable to ascertain whether or not the biopsied tissue is cancerous. Often, a lesion or other tissue to be biopsied is identified through use of an imaging technique such as a computerized axial tomography (CAT) scan, ultrasonography, magnetic resonance imaging, and mammography.


One problem commonly encountered, especially in breast biopsies, is that the lesion is so small that the biopsy reduces its size to the extent that it is no longer visible by the imaging method employed. In such circumstances, it is desirable to place an imaging marker at the site of the biopsy to enable the medical practitioner subsequently to locate the lesion quickly and accurately in the event complete removal of the affected tissue is indicated. This problem is currently met by placing an imaging marker at the biopsy area by means of a cannula or similar device housing the marker.


There are currently two primary types of marking devices. One of the primary types is referred to as vacuum assisted biopsy devices (VAB's). The VAB devices are many times integrated with a mammography imaging system. They include a large diameter cannula, approximately 9 to 12 gage, or probe that is inserted into the breast tissue. Instruments, such as a biopsy device and a marking device, are introduced into the breast tissue through the large diameter cannula to take biopsy samples or mark a biopsy location.


The other primary type is self-contained marking devices comprising a small diameter, approximately 14 to 17 gage, open-end cannula and a stylet slidably received within the cannula. A marker is located in the cannula and expelled out the open-end upon the advancing of the stylet relative to the cannula.


One disadvantage of the VAB system is the biopsy and marking tools are integrated with the mammography imaging system. The capital investment of this type of system is substantial. Also, the biopsy and marking tools are typically designed to work only with the large diameter probe, which tends to lock the hospital or medical professional into the same source for the imaging system and the biopsy and marking tools. The VAB systems are also intended for the same components to be reused, which requires sterilization after each step. The various components are also typically flexible to help insert them through the probe. The VAB systems also have a relatively large diameter probe, which, all things being equal, the larger the diameter, the greater trauma to the surrounding tissue and the greater the pain or discomfort for the patient.


The self-contained marking devices address these disadvantages of the VAB systems. Since the self-contained marking device is not integrally incorporated with a particular imaging system, the self-contained marking devices can be used with any suitable imaging system and are not limited to just mammography. This permits the hospital or medical professional to mix and match the available imaging systems and self-contained marking devices to obtain the desired performance and cost-effectiveness.


The self-contained marking devices are typically disposable, which negates the need to sterilize them after each use. They also have a much smaller diameter, resulting in much less trauma to the surrounding tissue and pain to the patient.


A disadvantage of the self-contained systems is that the cannula has an open tip through which the marker is expelled. The open tip is generally closed by the marker residing in the cannula. However, the marker does not completely close off the open tip and it is possible for tissue to enter the open end of the cannula during the positioning of the marking device. The presence of tissue inside the open end of the cannula can interfere or make more difficult the expelling of the marker from the cannula.


The possibility for tissue being present in the open end of the cannula is, to some extent, related to the distance that the cannula is inserted through the tissue to the marking site. Thus, the manner in which the marking device is located at the biopsy site can impact the presence of tissue in the open end of the cannula. For example, the self-contained systems are sometimes used in combination with a positioning cannula that is inserted into the tissue mass with a stylet closing the end of the positioning cannula. In such a configuration, the stylet is removed once the positioning cannula is properly located relative to the biopsy site. Both the biopsy device and the marking device can be inserted and withdrawn through the positioning cannula. The use of the positioning cannula reduces the distance that the open end of the marking device cannula must travel through the tissue.


Alternatively, the marking device can be inserted without the positioning cannula. This is most common when it is desirable to place a marker without taking a biopsy. Under such circumstances, it is more likely that tissue will be received within the open end of the cannula. Therefore, it is more likely that the tissue will interfere with the expelling of the marker.


Therefore, it is desirable to have a self-contained marking device that can be used with or without a positioning cannula and which does not receive tissue within the open end of the cannula that might interfere with the expelling of the marker.


SUMMARY OF THE INVENTION

The invention relates to a marking apparatus for the percutaneous placement of an imaging marker at a predetermined location in a tissue mass to facilitate subsequent determination of the predetermined location. The marking apparatus comprises a handle, cannula, and plunger. The handle is to be grasped by a user to aid in the placement of the marker.


The cannula comprises a peripheral wall forming a lumen, with a proximal end carried by the handle, and a distal end terminating in a self-piercing tip. A lateral opening is formed in the peripheral wall and is open to the lumen.


A plunger having a distal end is slidably received within the lumen for movement between a ready position, where the distal end is spaced inwardly from the self-piercing tip to form a marker recess in communication with the lateral opening and sized to receive an imaging marker, and an expelled position, where the distal end is advanced a sufficient distance into the marker recess to expel a marker contained therein through the lateral opening.


One or more imaging markers can be positioned within the marker recess.


The handle, cannula, plunger are operably coupled such that they form a self-contained marking apparatus that can be easily and conveniently handled by a user to effect operation of the marking apparatus from the ready position to an expelled position.


The cannula is preferably sufficiently rigid and a distal end of the cannula is pointed to form the self-piercing tip. The cannula is 13 gage or less.


A ramp can be provided on at least one of the plunger and cannula to aid in expelling an imaging marker. The ramp can be located in the lumen adjacent the lateral opening. The distal end of the plunger can be flexible to be deflected toward the lateral opening by the ramp when the plunger is moved to the expelled position. The ramp can also be located on the distal end of the plunger.


The invention, in one form thereof, is directed to a marking apparatus for the percutaneous placement of an imaging marker in a tissue mass. The marking apparatus includes a handle to be grasped by a user, a rigid cannula and a stylet. The rigid cannula has a peripheral wall forming a lumen that carries the imaging marker, a proximal end coupled to the handle, a lateral opening in the peripheral wall that is open to the lumen, and a closed-off distal portion having a ramp adjacent the lumen. The closed-off distal portion extends distally from the ramp to terminate at a tissue piercing pointed tip. The ramp of the rigid cannula is curved to transition from the peripheral wall of the rigid cannula to the lateral opening of the rigid cannula. A stylet has a distal end, with at least the distal end of the stylet being flexible. The stylet is slidably received within the lumen of the rigid cannula for movement in the lumen. The ramp of the rigid cannula is adapted to engage the distal end of the stylet as the stylet is advanced through the lumen of the rigid cannula to guide the distal end of the stylet to a position to substantially close off the lateral opening of the rigid cannula having the tissue piercing tip.


The invention, in another form thereof, is directed to a marking apparatus for the percutaneous placement of an imaging marker in a tissue mass. The marking apparatus includes a handle to be grasped by a user, a cannula, and a stylet. The cannula has a peripheral wall forming a lumen that carries the imaging marker, a proximal end coupled to the handle, a lateral opening in the peripheral wall that is open to the lumen, and a closed-off distal portion having a ramp adjacent the lumen. The closed-off distal portion extends distally from the ramp to terminate at a tissue piercing pointed tip. The stylet has a distal end with an angled surface. The stylet is disposed in the lumen and movable in the lumen between a ready position and an expelled position, such that when the stylet is advanced through the lumen to the expelled position the ramp deflects the distal end of the stylet toward the lateral opening such that at the expelled position the angled surface is flush with the peripheral wall of the cannula at the lateral opening of the cannula.


The invention, in another form thereof, is directed to a marking apparatus for the percutaneous placement of an imaging marker in a tissue mass. The marking apparatus includes a handle to be grasped by a user, a cannula, and a stylet. The cannula has a peripheral wall forming a lumen that carries the imaging marker, a proximal end carried by the handle, a closed-off distal portion terminating in a self-piercing tip, a ramp integrated with the closed-off distal portion, and a lateral opening in the peripheral wall. The lateral opening extends in a region between the proximal end and the closed-off distal portion of the cannula. The lateral opening has a proximal extent and a distal extent, the distal extent being closer to the self-piercing tip than the proximal extent. The stylet includes a distal end. The stylet is slidably received within the lumen for movement between a ready position, wherein the distal end of the stylet is spaced inwardly from the self-piercing tip to form a marker recess in communication with the lateral opening, and an expelled position, wherein the distal end of the stylet is advanced a sufficient distance into the marker recess to expel the imaging marker contained in the lumen through the lateral opening of the cannula. When the distal end of the stylet is at the expelled position the distal end of the stylet is deflected by the ramp to close off the lateral opening of the cannula between the proximal extent and the distal extent of the lateral opening.


The invention also relates to a method for percutaneously placing a marker at a predetermined location in a tissue mass using a self-piercing, side-ejecting, self-contained marking apparatus comprising a cannula defining a lumen and terminating in a self-piercing tip, with a lateral opening in communication with the lumen, and a plunger slidably received within the lumen for expelling a marker in the lumen through the lateral opening. The method comprises: inserting the cannula into the tissue mass by puncturing an exterior of the tissue mass with the self-piercing tip, and expelling the marker through the lateral opening by sliding the plunger within the lumen.


The inserting step can comprise locating the lateral opening near a predetermined location in the tissue mass where it is desired to be marked. Preferably, the lateral opening is located beneath the predetermined location.


The expelling step comprises expelling multiple markers into the tissue mass. At least one of the multiple markers can be expelled at a different location in the tissue mass than another of the multiple markers.





BRIEF DESCRIPTION OF THE DRAWINGS

In the drawings:



FIG. 1 is a plan view of a self-contained, self-piercing, and side-expelling marking apparatus comprising an actuator, a cannula with a side opening, and a stylet for laterally expelling a marker through the side opening in accordance with the invention.



FIG. 2 is an enlarged sectional view of the area II of FIG. 1, illustrating the relationship between the cannula, stylet and marker prior to the expelling of the marker.



FIG. 3. is an enlarged top view of the cannula tip of FIG. 2.



FIG. 4. is an enlarged sectional view of a portion of the actuator.



FIG. 5 is a sectional view of the marking device inserted into a tissue mass such that the cannula side opening is adjacent an area to be marked, with the stylet shown in a ready position and the marker still retained within the cannula lumen.



FIG. 6 is an enlarged sectional view of the cannula tip of FIG. 5.



FIG. 7 is a sectional view of the marking device inserted into a tissue mass such that the cannula side opening is adjacent an area to be marked, with the stylet shown in a expelled position and the marker expelled through the side opening into the surrounding tissue mass.



FIG. 8 is an enlarged sectional view of the cannula tip of FIG. 7.



FIG. 9 is a sectional view of an alternative design for the cannula and stylet according to the invention, with the stylet having a flexible tip and shown in the ready position.



FIG. 10 is a sectional view of the cannula and stylet of FIG. 9 with the stylet shown in the expelled position.



FIG. 11 is a sectional view of a second alternative design for the cannula and stylet according to the invention, with the stylet having a ramped tip and shown in the expelled position.





DETAILED DESCRIPTION


FIGS. 1-4 illustrate a self-contained, self-penetrating, side-expelling marking apparatus 10 according to the invention, which is capable of the percutaneous placement of a imaging marker at a desired location, such as at a tissue biopsy site or a lesion site in a breast. The marking apparatus 10 comprises an introducer 12 and an imaging marker 14 (FIG. 2) contained within the introducer 12. The introducer 12 includes an actuator 16 having a hollow interior 18. The actuator 16 comprises a grip portion 20 from which extends a tapered nose portion 22. The grip portion 20 defines a rear opening 24 that provides access to the hollow interior 18. A pair of detents 26 are formed in the grip portion 20 near the rear opening 24. Channels 28 are formed on the interior surface of the grip portion 20 and extend from the rear opening 24 to the detents 26.


The nose portion 22 comprises a guide passage 30 extending from the tip of the nose portion 22 to the hollow interior 18 of the actuator 16. The guide passage 30 decreases in diameter inwardly from the tip of the nose portion to form a cannula seat 32 (FIG. 5).


A plunger 50 comprises a cylindrical body 52 from which extend a pair of catches 54 at diametrically opposed positions. The cylindrical body 52 is sized so that it is slidably received within the rear opening 24 of the actuator 16 where it is so oriented with respect to the actuator such that the catches 54 are aligned with the guide channels 28. The plunger is free to reciprocate within the grip portion 20 of the actuator 16.


A cannula 60 is mounted to the introducer 12. The cannula 60 defines a hollow interior in the form of a lumen 62 and comprises a proximal end 64 and a distal end 66. The proximal end 64 (FIG. 5) is mounted within the cannula seat 32 to secure the cannula 60 to the introducer 12. The distal end 66 terminates in a closed-off tip 68 to provide the marking apparatus with self-piercing functionality. The closed-off tip 68 is illustrated as being pointed, but other suitable shapes are possible.


The cannula 60 is preferably 13 gage or less in size. The cannula 60 is also preferably rigid. That is, the cannula does not substantially flex. The rigidity of the cannula aids in inserting the cannula into a tissue mass, without the aid of a guide needle or guide cannula.


A side opening 70 is formed in the cannula 60 and extends entirely through the cannula such that the lumen 62 is in communication with the exterior of the cannula 60 through the side opening 70. The side opening is preferably located behind the closed-off tip 68.


A ramp 72 is provided on the interior of the cannula 60. The ramp 72 is illustrated as being integrally formed with the closed-off tip 68. Such a configuration can result in a solid distal end 66 as illustrated. However, the distal end can be hollow and the ramp 72 can be formed by separately from the distal end 66.


The ramp 72 extends diametrically across the lumen 62 and terminates at the side opening 70. With this configuration, the ramp 72 aids in directing an imaging marker 14 stored in the lumen through the side opening 70 and beyond the exterior of the cannula.


A stylet 80 comprising a shaft 82 and a base 84 is received within the hollow interior 18 of the actuator 16 in a manner such that the shaft 82 extends through the guide passage 30 and into the cannula interior 62 and the stylet base 84 lies within the hollow interior 18 and is mounted to the plunger 50. Thus, the reciprocation of the plunger 50 relative to the grip portion 20 results in a reciprocation of the stylet 80 within the cannula 60.


The stylet 80 terminates in a distal end 86, which, when the marking apparatus is in the ready position, is spaced from the distal end 66 of the cannula 60 to form a marker recess therebetween. As illustrated, a single marker 14 is stored within the marker recess. It is within the scope of the invention for multiple markers to be received within the marker recess.


As is shown, the foregoing construction provides a marking apparatus that is preassembled as a self-contained unit and prepackaged, all under sterile conditions, thereby affording the practitioner substantially greater convenience and reliability, while eliminating the need for sterilizing the self-contained unit after use. Preferably, the self-contained unit is disposed of after it is used.


Referring to FIGS. 5-8, in operation, the introducer 12 begins in the ready condition shown in FIGS. 5 and 6. In this condition, the distal end 86 of the stylet 80 is received within the cannula and spaced from the closed-off distal end 66 of the cannula to define a marker recess in which a marker 14 is stored. The plunger 50 is in a position relative to the grip portion 20 in which the catches are outside the grip portion; that is, they are not received within the detents 26. However, the plunger 50 is so oriented with respect to the grip portion that the catches 54 are aligned with the guide channels 28.


With the introducer in the ready condition, the cannula is positioned within the tissue mass such that the side opening 70 is at or near the location of a tissue mass where it is desired to place the marker. In the case of marking a biopsy site, the side opening is preferably placed adjacent the biopsy site.


To place the side opening adjacent the site to be marked, the medical professional grasps the grip portion 20 of the actuator and presses the closed-off tip 68 against the exterior of the tissue mass to puncture the tissue mass. The medical professional continues applying force to the grip portion 20 to drive the cannula 60 to the desired location within the tissue mass.


The closed tip 68 helps separate the tissue of the tissue mass to make it easier to insert the cannula within the tissue mass to the desired location. A starter incision can be made in the exterior of the tissue mass to reduce the initial force need to start the insertion.


The used of a side opening 70 instead of a tip opening found in the prior art self-contained devices helps prevent the accumulation of tissue within the lumen 62 upon the insertion of the cannula 60 into the tissue mass. The closed tip 68 also helps in that it separates the tissue to form a path through which the side opening passes. Since the side opening is parallel to the path, there is much less tendency for the insertion of the cannula to force tissue into the side opening as could occur in the prior-art front opening cannulae.


Typically, a suitable imaging system will be used by the medical professional to help guide the cannula to the desired location within the tissue mass. Examples of contemporary imaging systems include: stereotactic, x-ray, ultrasound, CAT scan, or MRI. The invention is not limited to any particular type of imaging system.


Once the cannula is positioned at the desired location, the plunger 50 is moved from a first or ready condition as illustrated in FIGS. 5 and 6 to a second or expelled condition as illustrated in FIGS. 7 and 8. As the plunger is moved, the stylet 80 is advanced into the marker recess to drive the marker 14 up the ramp 72. The continued advancement of the stylet 80 ultimately drives the marker 14 through the side opening 70 and into the adjacent tissue.


Once the stylet is in the expelled position, the cannula can be withdrawn to leave the marker in the tissue. To withdraw the cannula, the medical professional pulls on the actuator to withdraw the cannula from the tissue mass. After use, the marking apparatus is disposed of, negating the need for sterilization.


As illustrated, the rigid cannula in combination with the closed-off tip 68 provides an ideal structure for inserting the device directly into the tissue without the need for a guide needle or cannula. This is advantageous in that it reduces the size of the opening formed in the tissue and thereby reducing the trauma to the patient. The closed-off tip is used to puncture the exterior of the tissue mass. While the marking apparatus of the invention can be used with a guide needle or cannula, there is no need to do so because of the self-piercing nature of the invention.



FIGS. 9 and 10 illustrate an alternative design for the stylet in the ready and expelled conditions, respectively. The alternative stylet 80′ is essentially identical to the stylet 80, except that the distal end 66′ is made from a resilient material and has an angled surface 90′. The resilient material permits the distal end 66′ to deflect when contacting the ramp 72′, such that the distal end 66′ generally follows the shape of the ramp 72′. The angle of the angled surface 90′ is preferably selected such that the angled surface substantially closes off the side opening 70′ when the stylet is in the expelled condition, which will ensure that the marker is completely expelled through the side opening 70′. It will also ensure that no portion of the marker 14 will be pulled back into the side opening 70′ due to the vacuum forces created upon the withdrawal of the cannula. The angled surface 90′ functions like the ramp 72 in that it helps to deflect the marker 14 through the side opening.



FIG. 11 illustrates another alternative design for the stylet and cannula. In this alternative design, the distal end 66″ of the stylet 80″ includes a ramp 72″. A resilient end wall 92″ is used instead of the ramp 72 of the cannula. The space between the ramp 72″ and the resilient end wall 92″ defines the marker recess in which multiple markers 14″ are stored. The advancement of the stylet from the ready condition to the expelled condition drives the markers up the ramp 72″. When contacted by the ramp 72″, the resilient end wall 92″ deflects to permit the ramp 72″ to slide beneath and into the distal end closed tip 68″ of the cannula.


In all of the embodiments, multiple markers can be located within the cannula and expelled at the same or different locations within the tissue mass.


While the invention has been specifically described in connection with certain specific embodiments thereof, it is to be understood that this is by way of illustration and not of limitation, and the scope of the appended claims should be construed as broadly as the prior art will permit.

Claims
  • 1. A method of operating a tissue marking apparatus, comprising: providing a tissue marking apparatus having a cannula, a stylet, and an imaging marker, the cannula having a peripheral wall forming a lumen and a lateral opening in the peripheral wall that is open to the lumen, and having a resilient end wall extending downwardly from the peripheral wall at a distal extent of the lateral opening, the stylet being slidably received within the lumen of the cannula for movement in the lumen;moving the stylet in a distal direction to expel the imaging marker from the lateral opening; andcontinue moving the stylet in the distal direction to deflect the resilient end wall of the cannula such that a distal end of the stylet passes beneath the resilient end wall to substantially close off the lateral opening of the cannula.
  • 2. The method of claim 1, wherein only the stylet and the resilient end wall close off the lateral opening when the stylet is in an extended position.
  • 3. The method of claim 1, comprising: positioning the stylet in a ready position wherein a distal end of the stylet is positioned in the lumen proximal to an extended position to form a marker recess to carry the imaging marker; andthe act of moving moves the stylet to the extended position to substantially close off the lateral opening of the cannula only after the imaging marker is expelled.
  • 4. The method of claim 3, comprising positioning multiple imaging markers within the marker recess.
  • 5. The method of claim 1, comprising latching the stylet in an extended position.
  • 6. A method of operating a tissue marking apparatus, comprising: providing a tissue marking apparatus having a handle, a cannula, a stylet, and an imaging marker, the cannula having a peripheral wall forming a lumen that carries the imaging marker, a proximal end coupled to the handle, a lateral opening in the peripheral wall that is open to the lumen, a closed-off distal portion having a distal void and a pointed tip, wherein the distal void is distal to the lateral opening and is proximal to the pointed tip, and a resilient end wall proximal to the distal void, the stylet having a distal end with an angled surface, the stylet being disposed in the lumen and movable in the lumen;advancing the stylet through the lumen to expel the imaging marker out of the lumen through the lateral opening of the cannula; andfurther advancing the stylet through the lumen to deflect the resilient end wall and to pass beneath the resilient end wall and into the distal void.
  • 7. The method of claim 6, wherein the resilient end wall cantilevers from the peripheral wall of the cannula to separate the distal void from the lateral opening.
  • 8. The method of claim 6, wherein the stylet closes off the lateral opening after the imaging marker is expelled.
  • 9. The method of claim 8, wherein after the imaging marker is expelled, further comprising latching the stylet.
  • 10. A method of operating a tissue marking apparatus, comprising: providing a tissue marking apparatus having a cannula, a stylet, and an imaging marker, the cannula having a lumen, a lateral opening in a peripheral wall, a cantilever end wall extending into the lumen from the peripheral wall, and a closed-off distal portion, the cantilever end wall having a distal free end that is suspended in the lumen above the peripheral wall;moving a stylet within the lumen to expel an imaging marker from the lateral opening of the cannula; andcontinuing movement of the stylet in the lumen of the cannula to deflect the cantilever end wall and to pass the stylet beneath the cantilever end wall and into the closed-off distal portion.
  • 11. The method of claim 10, wherein the stylet has an angled end surface to engage the cantilever end wall.
  • 12. The method of claim 10, comprising latching the stylet in an extended position.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. application Ser. No. 15/381,717 filed Dec. 16, 2016, now U.S. Pat. No. 9,848,956, which is a divisional of U.S. application Ser. No. 15/078,847 filed Mar. 23, 2016, now abandoned, which is a continuation of U.S. application Ser. No. 12/850,844 filed Aug. 5, 2010, now abandoned, which is a continuation of U.S. application Ser. No. 11/275,918 filed Feb. 3, 2006, now U.S. Pat. No. 7,819,820, which is a continuation of U.S. application Ser. No. 10/710,587 filed Jul. 22, 2004, now abandoned, and is a continuation-in-part of U.S. application Ser. No. 10/707,044 filed Nov. 17, 2003, now U.S. Pat. No. 7,424,320, issued Sep. 9, 2008, which claims the benefit of U.S. Provisional Application Ser. No. 60/427,048 filed Nov. 18, 2002, all of which are incorporated herein by reference in their entirety.

US Referenced Citations (596)
Number Name Date Kind
2899362 Sieger, Jr. et al. Aug 1959 A
2907327 White Oct 1959 A
3005457 Millman Oct 1961 A
3128744 Jefferts et al. Apr 1964 A
3402712 Eisenhand Sep 1968 A
3516412 Ackerman Jun 1970 A
3818894 Wichterle et al. Jun 1974 A
3820545 Jefferts Jun 1974 A
3823212 Chvapil Jul 1974 A
3921632 Bardani Nov 1975 A
4005699 Bucalo Feb 1977 A
4007732 Kvavle et al. Feb 1977 A
4041931 Elliott et al. Aug 1977 A
4086914 Moore May 1978 A
4103690 Harris Aug 1978 A
4105030 Kercso Aug 1978 A
4127774 Gillen Nov 1978 A
4172449 LeRoy et al. Oct 1979 A
4197846 Bucalo Apr 1980 A
4217889 Radovan et al. Aug 1980 A
4228799 Anichkov et al. Oct 1980 A
4276885 Tickner et al. Jul 1981 A
4294241 Miyata Oct 1981 A
4298998 Naficy Nov 1981 A
4331654 Morris May 1982 A
4347234 Wahlig et al. Aug 1982 A
4390018 Zukowski Jun 1983 A
4400170 McNaughton et al. Aug 1983 A
4401124 Guess et al. Aug 1983 A
4405314 Cope Sep 1983 A
4428082 Naficy Jan 1984 A
4438253 Casey et al. Mar 1984 A
4442843 Rasor et al. Apr 1984 A
4470160 Cavon Sep 1984 A
4487209 Mehl Dec 1984 A
4545367 Tucci Oct 1985 A
4582061 Fry Apr 1986 A
4582640 Smestad et al. Apr 1986 A
4588395 Lemelson May 1986 A
4597753 Turley Jul 1986 A
4647480 Ahmed Mar 1987 A
4655226 Lee Apr 1987 A
4661103 Harman Apr 1987 A
4682606 DeCaprio Jul 1987 A
4693237 Hoffman et al. Sep 1987 A
4718433 Feinstein Jan 1988 A
4740208 Cavon Apr 1988 A
4762128 Rosenbluth Aug 1988 A
4813062 Gilpatrick Mar 1989 A
4820267 Harman Apr 1989 A
4832680 Haber et al. May 1989 A
4832686 Anderson May 1989 A
4847049 Yamamoto Jul 1989 A
4863470 Carter Sep 1989 A
4870966 Dellon et al. Oct 1989 A
4874376 Hawkins, Jr. Oct 1989 A
4889707 Day et al. Dec 1989 A
4909250 Smith Mar 1990 A
4931059 Markham Jun 1990 A
4938763 Dunn et al. Jul 1990 A
4950234 Fujioka et al. Aug 1990 A
4950665 Floyd Aug 1990 A
4963150 Brauman Oct 1990 A
4970298 Silver et al. Nov 1990 A
4989608 Ratner Feb 1991 A
4994013 Suthanthiran et al. Feb 1991 A
4994028 Leonard et al. Feb 1991 A
5012818 Joishy May 1991 A
5013090 Matsuura May 1991 A
5018530 Rank et al. May 1991 A
5035891 Runkel et al. Jul 1991 A
5059197 Urie et al. Oct 1991 A
5081997 Bosley, Jr. et al. Jan 1992 A
5120802 Mares et al. Jun 1992 A
5125413 Baran Jun 1992 A
5137928 Erbel et al. Aug 1992 A
5141748 Rizzo Aug 1992 A
5147295 Stewart Sep 1992 A
5147307 Gluck Sep 1992 A
5147631 Glajch et al. Sep 1992 A
5162430 Rhee et al. Nov 1992 A
5163896 Suthanthiran et al. Nov 1992 A
5195540 Shiber Mar 1993 A
5197482 Rank et al. Mar 1993 A
5199441 Hogle Apr 1993 A
5201704 Ray Apr 1993 A
5219339 Saito Jun 1993 A
5221269 Miller et al. Jun 1993 A
5234426 Rank et al. Aug 1993 A
5236410 Granov et al. Aug 1993 A
5242759 Hall Sep 1993 A
5250026 Ehrlich et al. Oct 1993 A
5271961 Mathiowitz et al. Dec 1993 A
5273532 Niezink et al. Dec 1993 A
5280788 Janes et al. Jan 1994 A
5281197 Arias et al. Jan 1994 A
5281408 Unger Jan 1994 A
5282781 Liprie Feb 1994 A
5284479 de Jong Feb 1994 A
5289831 Bosley Mar 1994 A
5290310 Makower et al. Mar 1994 A
5312435 Nash et al. May 1994 A
5320100 Herweck et al. Jun 1994 A
5320613 Houge et al. Jun 1994 A
5328955 Rhee et al. Jul 1994 A
5334216 Vidal et al. Aug 1994 A
5334381 Unger Aug 1994 A
5344640 Deutsch et al. Sep 1994 A
5353804 Komberg et al. Oct 1994 A
5354623 Hall Oct 1994 A
5358514 Schulman et al. Oct 1994 A
5360416 Ausherman et al. Nov 1994 A
5366756 Chesterfield et al. Nov 1994 A
5368030 Zinreich et al. Nov 1994 A
5388588 Nabai et al. Feb 1995 A
5394875 Lewis et al. Mar 1995 A
5395319 Hirsch et al. Mar 1995 A
5405402 Dye et al. Apr 1995 A
5409004 Sloan Apr 1995 A
5417708 Hall et al. May 1995 A
5422730 Barlow et al. Jun 1995 A
5425366 Reinhardt et al. Jun 1995 A
5431639 Shaw Jul 1995 A
5433204 Olson Jul 1995 A
5449560 Antheunis et al. Sep 1995 A
5451406 Lawin et al. Sep 1995 A
5458643 Oka et al. Oct 1995 A
5460182 Goodman et al. Oct 1995 A
5469847 Zinreich et al. Nov 1995 A
5475052 Rhee et al. Dec 1995 A
5490521 Davis et al. Feb 1996 A
5494030 Swartz et al. Feb 1996 A
5499989 LaBash Mar 1996 A
5507807 Shippert Apr 1996 A
5508021 Grinstaff et al. Apr 1996 A
5514085 Yoon May 1996 A
5522896 Prescott Jun 1996 A
5538726 Order Jul 1996 A
5542915 Edwards et al. Aug 1996 A
5545180 Le et al. Aug 1996 A
5549560 Van de Wijdeven Aug 1996 A
5567413 Klaveness et al. Oct 1996 A
RE35391 Brauman Dec 1996 E
5580568 Greff et al. Dec 1996 A
5585112 Unger et al. Dec 1996 A
5611352 Kobren et al. Mar 1997 A
5626611 Liu et al. May 1997 A
5628781 Williams et al. May 1997 A
5629008 Lee May 1997 A
5636255 Ellis Jun 1997 A
5643246 Leeb et al. Jul 1997 A
5646146 Faarup et al. Jul 1997 A
5651772 Arnett Jul 1997 A
5657366 Nakayama Aug 1997 A
5665092 Mangiardi et al. Sep 1997 A
5667767 Greff et al. Sep 1997 A
5669882 Pyles Sep 1997 A
5673841 Schulze et al. Oct 1997 A
5676146 Scarborough Oct 1997 A
5676925 Klaveness et al. Oct 1997 A
5688490 Tournier et al. Nov 1997 A
5690120 Jacobsen et al. Nov 1997 A
5695480 Evans et al. Dec 1997 A
5702128 Maxim et al. Dec 1997 A
5702682 Thompson Dec 1997 A
5702716 Dunn et al. Dec 1997 A
5716981 Hunter et al. Feb 1998 A
5747060 Sackler et al. May 1998 A
5749887 Heske et al. May 1998 A
5752974 Rhee et al. May 1998 A
5762903 Park et al. Jun 1998 A
5769086 Ritchart et al. Jun 1998 A
5776496 Violante et al. Jul 1998 A
5779647 Chau et al. Jul 1998 A
5782764 Werne Jul 1998 A
5782771 Hussman Jul 1998 A
5782775 Milliman et al. Jul 1998 A
5795308 Russin Aug 1998 A
5799099 Wang et al. Aug 1998 A
5800362 Kobren et al. Sep 1998 A
5800389 Burney et al. Sep 1998 A
5800445 Ratcliff et al. Sep 1998 A
5800541 Rhee et al. Sep 1998 A
5810884 Kim Sep 1998 A
5817022 Vesely Oct 1998 A
5820918 Ronan et al. Oct 1998 A
5821184 Haines et al. Oct 1998 A
5823198 Jones et al. Oct 1998 A
5824042 Lombardi et al. Oct 1998 A
5824081 Knapp et al. Oct 1998 A
5826776 Schulze et al. Oct 1998 A
5830178 Jones et al. Nov 1998 A
5830222 Makower Nov 1998 A
5842477 Naughton et al. Dec 1998 A
5842999 Pruitt et al. Dec 1998 A
5845646 Lemelson Dec 1998 A
5846220 Elsberry Dec 1998 A
5851508 Greff et al. Dec 1998 A
5853366 Dowlatshahi Dec 1998 A
5865806 Howell Feb 1999 A
5869080 McGregor et al. Feb 1999 A
5871501 Leschinsky et al. Feb 1999 A
5876340 Tu et al. Mar 1999 A
5879357 Heaton et al. Mar 1999 A
5891558 Bell et al. Apr 1999 A
5897507 Kortenbach et al. Apr 1999 A
5902310 Foerster et al. May 1999 A
5911705 Howell Jun 1999 A
5916164 Fitzpatrick et al. Jun 1999 A
5921933 Sarkis et al. Jul 1999 A
5922024 Janzen et al. Jul 1999 A
5928626 Klaveness et al. Jul 1999 A
5928773 Andersen Jul 1999 A
5941439 Kammerer et al. Aug 1999 A
5941890 Voegele et al. Aug 1999 A
5942209 Leavitt et al. Aug 1999 A
5948425 Janzen et al. Sep 1999 A
5954670 Baker Sep 1999 A
5972817 Haines et al. Oct 1999 A
5976146 Ogawa et al. Nov 1999 A
5980564 Stinson Nov 1999 A
5989265 Bouquet De La Joliniere et al. Nov 1999 A
6015541 Greff et al. Jan 2000 A
6027471 Fallon et al. Feb 2000 A
6030333 Sioshansi et al. Feb 2000 A
6053925 Barnhart Apr 2000 A
6056700 Burney et al. May 2000 A
6066122 Fisher May 2000 A
6066325 Wallace et al. May 2000 A
6071301 Cragg et al. Jun 2000 A
6071310 Picha et al. Jun 2000 A
6071496 Stein et al. Jun 2000 A
6090996 Li Jul 2000 A
6096065 Crowley Aug 2000 A
6096070 Ragheb et al. Aug 2000 A
6106473 Violante et al. Aug 2000 A
6117108 Woehr et al. Sep 2000 A
6120536 Ding et al. Sep 2000 A
6135993 Hussman Oct 2000 A
6142955 Farascioni et al. Nov 2000 A
6159240 Sparer et al. Dec 2000 A
6159445 Klaveness et al. Dec 2000 A
6161034 Burbank et al. Dec 2000 A
6162192 Cragg et al. Dec 2000 A
6166079 Follen et al. Dec 2000 A
6173715 Sinanan et al. Jan 2001 B1
6174330 Stinson Jan 2001 B1
6177062 Stein et al. Jan 2001 B1
6181960 Jensen et al. Jan 2001 B1
6183497 Sing et al. Feb 2001 B1
6190350 Davis et al. Feb 2001 B1
6190353 Makower et al. Feb 2001 B1
6200258 Slater et al. Mar 2001 B1
6203507 Wadsworth et al. Mar 2001 B1
6203524 Burney et al. Mar 2001 B1
6203568 Lombardi et al. Mar 2001 B1
6213957 Milliman et al. Apr 2001 B1
6214045 Corbitt, Jr. et al. Apr 2001 B1
6214315 Greff et al. Apr 2001 B1
6220248 Voegele et al. Apr 2001 B1
6224630 Bao et al. May 2001 B1
6228049 Schroeder et al. May 2001 B1
6228055 Foerster et al. May 2001 B1
6231615 Preissman May 2001 B1
6234177 Barsch May 2001 B1
6241687 Voegele et al. Jun 2001 B1
6241734 Scribner et al. Jun 2001 B1
6251135 Stinson et al. Jun 2001 B1
6251418 Ahern et al. Jun 2001 B1
6261243 Burney et al. Jul 2001 B1
6261302 Voegele et al. Jul 2001 B1
6264917 Klaveness et al. Jul 2001 B1
6270464 Fulton, III et al. Aug 2001 B1
6270472 Antaki et al. Aug 2001 B1
6287278 Woehr et al. Sep 2001 B1
6287332 Bolz et al. Sep 2001 B1
6289229 Crowley Sep 2001 B1
6306154 Hudson et al. Oct 2001 B1
6312429 Burbank et al. Nov 2001 B1
6316522 Loomis et al. Nov 2001 B1
6325789 Janzen et al. Dec 2001 B1
6335029 Kamath et al. Jan 2002 B1
6336904 Nikolchev Jan 2002 B1
6340367 Stinson et al. Jan 2002 B1
6343227 Crowley Jan 2002 B1
6347240 Foley et al. Feb 2002 B1
6347241 Burbank et al. Feb 2002 B2
6350244 Fisher Feb 2002 B1
6350274 Li Feb 2002 B1
6354989 Nudeshima Mar 2002 B1
6356112 Tran et al. Mar 2002 B1
6356782 Sirimanne et al. Mar 2002 B1
6358217 Bourassa Mar 2002 B1
6363940 Krag Apr 2002 B1
6371904 Sirimanne et al. Apr 2002 B1
6394965 Klein May 2002 B1
6403758 Loomis Jun 2002 B1
6405733 Fogarty et al. Jun 2002 B1
6409742 Fulton, III et al. Jun 2002 B1
6419621 Sioshansi et al. Jul 2002 B1
6424857 Henrichs et al. Jul 2002 B1
6425903 Voegele Jul 2002 B1
6427081 Burbank et al. Jul 2002 B1
6436030 Rehil Aug 2002 B2
6447524 Knodel et al. Sep 2002 B1
6447527 Thompson et al. Sep 2002 B1
6450937 Mercereau et al. Sep 2002 B1
6450938 Miller Sep 2002 B1
6471700 Burbank et al. Oct 2002 B1
6478790 Bardani Nov 2002 B2
6506156 Jones et al. Jan 2003 B1
6511468 Cragg et al. Jan 2003 B1
6511650 Eiselt et al. Jan 2003 B1
6537193 Lennox Mar 2003 B1
6540981 Klaveness et al. Apr 2003 B2
6544185 Montegrande Apr 2003 B2
6544231 Palmer et al. Apr 2003 B1
6544269 Osborne et al. Apr 2003 B2
6551253 Worm et al. Apr 2003 B2
6554760 Lamoureux et al. Apr 2003 B2
6562317 Greff et al. May 2003 B2
6564806 Fogarty et al. May 2003 B1
6565551 Jones et al. May 2003 B1
6567689 Burbank et al. May 2003 B2
6575888 Zamora et al. Jun 2003 B2
6575991 Chesbrough et al. Jun 2003 B1
6585773 Xie Jul 2003 B1
6605047 Zarins et al. Aug 2003 B2
6610026 Cragg et al. Aug 2003 B2
6613002 Clark et al. Sep 2003 B1
6616630 Woehr et al. Sep 2003 B1
6626850 Chau et al. Sep 2003 B1
6626899 Houser et al. Sep 2003 B2
6628982 Thomas et al. Sep 2003 B1
6629947 Sahatjian et al. Oct 2003 B1
6636758 Sanchez et al. Oct 2003 B2
6638234 Burbank et al. Oct 2003 B2
6638308 Corbitt, Jr. et al. Oct 2003 B2
6652442 Gatto Nov 2003 B2
6656192 Espositio et al. Dec 2003 B2
6659933 Asano Dec 2003 B2
6662041 Burbank et al. Dec 2003 B2
6699205 Fulton, III et al. Mar 2004 B2
6712774 Voegele et al. Mar 2004 B2
6712836 Berg et al. Mar 2004 B1
6716444 Castro et al. Apr 2004 B1
6725083 Burbank et al. Apr 2004 B1
6730042 Fulton et al. May 2004 B2
6730044 Stephens et al. May 2004 B2
6746661 Kaplan Jun 2004 B2
6746773 Llanos et al. Jun 2004 B2
6752154 Fogarty et al. Jun 2004 B2
6766186 Hoyns et al. Jul 2004 B1
6774278 Ragheb et al. Aug 2004 B1
6780179 Lee et al. Aug 2004 B2
6824507 Miller Nov 2004 B2
6824527 Gollobin Nov 2004 B2
6846320 Ashby et al. Jan 2005 B2
6862470 Burbank et al. Mar 2005 B2
6863685 Davila et al. Mar 2005 B2
6881226 Corbitt, Jr. et al. Apr 2005 B2
6889833 Seiler et al. May 2005 B2
6899731 Li et al. May 2005 B2
6918927 Bates et al. Jul 2005 B2
6936014 Vetter et al. Aug 2005 B2
6939318 Stenzel Sep 2005 B2
6945973 Bray Sep 2005 B2
6951564 Espositio et al. Oct 2005 B2
6958044 Burbank et al. Oct 2005 B2
6992233 Drake et al. Jan 2006 B2
6993375 Burbank et al. Jan 2006 B2
6994712 Fisher et al. Feb 2006 B1
6996433 Burbank et al. Feb 2006 B2
7001341 Gellman et al. Feb 2006 B2
7008382 Adams et al. Mar 2006 B2
7014610 Koulik Mar 2006 B2
7025765 Balbierz et al. Apr 2006 B2
7044957 Foerster et al. May 2006 B2
7047063 Burbank et al. May 2006 B2
7083576 Zarins et al. Aug 2006 B2
7125397 Woehr et al. Oct 2006 B2
7135978 Gisselberg et al. Nov 2006 B2
7160258 Imran et al. Jan 2007 B2
7172549 Slater et al. Feb 2007 B2
7189206 Quick et al. Mar 2007 B2
7214211 Woehr et al. May 2007 B2
7229417 Foerster et al. Jun 2007 B2
7236816 Kumar et al. Jun 2007 B2
7264613 Woehr et al. Sep 2007 B2
7280865 Adler Oct 2007 B2
7294118 Saulenas et al. Nov 2007 B2
7297725 Winterton et al. Nov 2007 B2
7329402 Unger et al. Feb 2008 B2
7329414 Fisher et al. Feb 2008 B2
7407054 Seiler et al. Aug 2008 B2
7416533 Gellman et al. Aug 2008 B2
7424320 Chesbrough et al. Sep 2008 B2
7449000 Adams et al. Nov 2008 B2
7527610 Erickson May 2009 B2
7534452 Chernomorsky et al. May 2009 B2
7535363 Gisselberg et al. May 2009 B2
7565191 Burbank et al. Jul 2009 B2
7569065 Chesbrough et al. Aug 2009 B2
7577473 Davis et al. Aug 2009 B2
7637948 Corbitt, Jr. Dec 2009 B2
7651505 Lubock et al. Jan 2010 B2
7668582 Sirimanne et al. Feb 2010 B2
7670350 Selis Mar 2010 B2
7783336 Macfarlane et al. Aug 2010 B2
7792569 Burbank et al. Sep 2010 B2
7819819 Quick et al. Oct 2010 B2
7819820 Field et al. Oct 2010 B2
7844319 Susil et al. Nov 2010 B2
7871438 Corbitt, Jr. Jan 2011 B2
7877133 Burbank et al. Jan 2011 B2
7914553 Ferree Mar 2011 B2
7945307 Lubock et al. May 2011 B2
7983734 Jones et al. Jul 2011 B2
8011508 Seiler et al. Sep 2011 B2
8027712 Sioshansi et al. Sep 2011 B2
8052658 Field Nov 2011 B2
8052708 Chesbrough et al. Nov 2011 B2
8064987 Carr, Jr. Nov 2011 B2
8128641 Wardle Mar 2012 B2
8157862 Corbitt, Jr. Apr 2012 B2
8177792 Lubock et al. May 2012 B2
8306602 Sirimanne et al. Nov 2012 B2
8320993 Sirimanne et al. Nov 2012 B2
8320994 Sirimanne et al. Nov 2012 B2
8361082 Jones et al. Jan 2013 B2
8401622 Talpade et al. Mar 2013 B2
8579931 Chesbrough et al. Nov 2013 B2
8626269 Jones et al. Jan 2014 B2
8626270 Burbank et al. Jan 2014 B2
8639315 Burbank et al. Jan 2014 B2
8668737 Corbitt, Jr. Mar 2014 B2
8680498 Corbitt et al. Mar 2014 B2
8718745 Burbank et al. May 2014 B2
8784433 Lubock et al. Jul 2014 B2
8965486 Burbank et al. Feb 2015 B2
9044162 Jones et al. Jun 2015 B2
9149341 Jones et al. Oct 2015 B2
9237937 Burbank et al. Jan 2016 B2
9480554 Corbitt, Jr. et al. Nov 2016 B2
9861294 Jones et al. Jan 2018 B2
20010006616 Leavitt et al. Jul 2001 A1
20020004060 Heublein et al. Jan 2002 A1
20020016625 Falotico et al. Feb 2002 A1
20020022883 Burg Feb 2002 A1
20020026201 Foerster et al. Feb 2002 A1
20020044969 Harden et al. Apr 2002 A1
20020045842 Van Bladel et al. Apr 2002 A1
20020052572 Franco et al. May 2002 A1
20020055731 Atala et al. May 2002 A1
20020058868 Hoshino et al. May 2002 A1
20020058882 Fulton, III et al. May 2002 A1
20020077687 Ahn Jun 2002 A1
20020082517 Klein Jun 2002 A1
20020082519 Miller et al. Jun 2002 A1
20020082682 Barclay et al. Jun 2002 A1
20020082683 Stinson et al. Jun 2002 A1
20020095204 Thompson et al. Jul 2002 A1
20020095205 Edwin et al. Jul 2002 A1
20020107437 Sirimanne et al. Aug 2002 A1
20020133148 Daniel et al. Sep 2002 A1
20020143359 Fulton, III et al. Oct 2002 A1
20020165608 Llanos et al. Nov 2002 A1
20020177776 Crawford Kellar et al. Nov 2002 A1
20020188195 Mills Dec 2002 A1
20020193815 Foerster et al. Dec 2002 A1
20020193867 Gladdish, Jr. et al. Dec 2002 A1
20030032969 Gannoe et al. Feb 2003 A1
20030036803 McGhan Feb 2003 A1
20030051735 Pavcnik et al. Mar 2003 A1
20030116806 Kato Jun 2003 A1
20030165478 Sokoll Sep 2003 A1
20030191355 Ferguson Oct 2003 A1
20030199887 Ferrera et al. Oct 2003 A1
20030225420 Wardle Dec 2003 A1
20030236573 Evans et al. Dec 2003 A1
20040001841 Nagavarapu et al. Jan 2004 A1
20040002650 Mandrusov et al. Jan 2004 A1
20040016195 Archuleta Jan 2004 A1
20040024304 Foerster et al. Feb 2004 A1
20040059341 Gellman et al. Mar 2004 A1
20040068312 Sigg et al. Apr 2004 A1
20040073284 Bates et al. Apr 2004 A1
20040097981 Selis May 2004 A1
20040101479 Burbank et al. May 2004 A1
20040101548 Pendharkar May 2004 A1
20040106891 Langan et al. Jun 2004 A1
20040116802 Jessop et al. Jun 2004 A1
20040127765 Seiler et al. Jul 2004 A1
20040133124 Bates et al. Jul 2004 A1
20040153074 Bojarski et al. Aug 2004 A1
20040162574 Viola Aug 2004 A1
20040167619 Case et al. Aug 2004 A1
20040204660 Fulton et al. Oct 2004 A1
20040210208 Paul et al. Oct 2004 A1
20040213756 Michal et al. Oct 2004 A1
20040236213 Jones et al. Nov 2004 A1
20040253185 Herweck et al. Dec 2004 A1
20040265371 Looney et al. Dec 2004 A1
20050019262 Chernomorsky et al. Jan 2005 A1
20050020916 MacFarlane et al. Jan 2005 A1
20050033157 Klien et al. Feb 2005 A1
20050033195 Fulton et al. Feb 2005 A1
20050036946 Pathak et al. Feb 2005 A1
20050045192 Fulton et al. Mar 2005 A1
20050059887 Mostafavi et al. Mar 2005 A1
20050059888 Sirimanne et al. Mar 2005 A1
20050065354 Roberts Mar 2005 A1
20050065453 Shabaz et al. Mar 2005 A1
20050080337 Sirimanne et al. Apr 2005 A1
20050080339 Sirimanne et al. Apr 2005 A1
20050100580 Osborne et al. May 2005 A1
20050112151 Horng May 2005 A1
20050113659 Pothier et al. May 2005 A1
20050119562 Jones et al. Jun 2005 A1
20050142161 Freeman et al. Jun 2005 A1
20050143650 Winkel Jun 2005 A1
20050165305 Foerster et al. Jul 2005 A1
20050175657 Hunter et al. Aug 2005 A1
20050181007 Hunter et al. Aug 2005 A1
20050208122 Allen et al. Sep 2005 A1
20050234336 Beckman et al. Oct 2005 A1
20050268922 Conrad et al. Dec 2005 A1
20050273002 Goosen et al. Dec 2005 A1
20050277871 Selis Dec 2005 A1
20060004440 Stinson Jan 2006 A1
20060009800 Christianson et al. Jan 2006 A1
20060025677 Verard et al. Feb 2006 A1
20060025795 Chesbrough et al. Feb 2006 A1
20060036158 Field et al. Feb 2006 A1
20060036159 Sirimanne et al. Feb 2006 A1
20060074443 Foerster et al. Apr 2006 A1
20060079770 Sirimanne et al. Apr 2006 A1
20060079805 Miller et al. Apr 2006 A1
20060079829 Fulton et al. Apr 2006 A1
20060079888 Mulier et al. Apr 2006 A1
20060122503 Burbank et al. Jun 2006 A1
20060155190 Burbank et al. Jul 2006 A1
20060173280 Goosen et al. Aug 2006 A1
20060173296 Miller et al. Aug 2006 A1
20060177379 Asgari Aug 2006 A1
20060217635 McCombs et al. Sep 2006 A1
20060235298 Kotmel et al. Oct 2006 A1
20060241385 Dietz Oct 2006 A1
20060241411 Field et al. Oct 2006 A1
20060292690 Liu et al. Dec 2006 A1
20070021642 Lamoureux et al. Jan 2007 A1
20070038145 Field Feb 2007 A1
20070083132 Sharrow Apr 2007 A1
20070106152 Kantrowitz et al. May 2007 A1
20070135711 Chernomorsky et al. Jun 2007 A1
20070142725 Hardin et al. Jun 2007 A1
20070167736 Dietz et al. Jul 2007 A1
20070167749 Yarnall et al. Jul 2007 A1
20070239118 Ono et al. Oct 2007 A1
20070287933 Phan et al. Dec 2007 A1
20080039819 Jones et al. Feb 2008 A1
20080091120 Fisher Apr 2008 A1
20080097199 Mullen Apr 2008 A1
20080188768 Zarins et al. Aug 2008 A1
20080269638 Cooke et al. Oct 2008 A1
20080294039 Jones et al. Nov 2008 A1
20090000629 Hornscheidt et al. Jan 2009 A1
20090024225 Stubbs Jan 2009 A1
20090030309 Jones et al. Jan 2009 A1
20090069713 Adams et al. Mar 2009 A1
20090076484 Fukaya Mar 2009 A1
20090131825 Burbank et al. May 2009 A1
20090171198 Jones et al. Jul 2009 A1
20090216118 Jones et al. Aug 2009 A1
20090287078 Burbank et al. Nov 2009 A1
20100010342 Burbank et al. Jan 2010 A1
20100030072 Casanova et al. Feb 2010 A1
20100082102 Govil et al. Apr 2010 A1
20100198059 Burbank et al. Aug 2010 A1
20100204570 Lubock Aug 2010 A1
20100298696 Field et al. Nov 2010 A1
20100324416 Burbank et al. Dec 2010 A1
20110092815 Burbank et al. Apr 2011 A1
20110184280 Jones et al. Jul 2011 A1
20120078092 Jones et al. Mar 2012 A1
20120179251 Corbitt, Jr. Jul 2012 A1
20130144157 Jones et al. Jun 2013 A1
20130281847 Jones et al. Oct 2013 A1
20130310686 Jones et al. Nov 2013 A1
20140058258 Chesbrough et al. Feb 2014 A1
20140114186 Burbank et al. Apr 2014 A1
20140142696 Corbitt, Jr. May 2014 A1
20140243675 Burbank et al. Aug 2014 A1
20160120510 Burbank et al. May 2016 A1
20160128797 Burbank et al. May 2016 A1
20160199150 Field et al. Jul 2016 A1
Foreign Referenced Citations (47)
Number Date Country
1029528 May 1958 DE
0146699 Jul 1985 EP
0255123 Feb 1988 EP
0292936 Nov 1988 EP
0458745 Nov 1991 EP
0475077 Mar 1992 EP
0552924 Jul 1993 EP
0769281 Apr 1997 EP
1114618 Jul 2001 EP
1163888 Dec 2001 EP
1281416 Jun 2002 EP
1364628 Nov 2003 EP
1493451 Jan 2005 EP
1767167 Mar 2007 EP
2646674 Nov 1990 FR
2853521 Oct 2004 FR
708148 Apr 1954 GB
2131757 May 1990 JP
2006516468 Jul 2006 JP
8906978 Aug 1989 WO
9112823 Sep 1991 WO
9314712 Aug 1993 WO
9317671 Sep 1993 WO
9317718 Sep 1993 WO
9416647 Aug 1994 WO
9507057 Mar 1995 WO
9806346 Feb 1998 WO
9908607 Feb 1999 WO
9935966 Jul 1999 WO
951143 Oct 1999 WO
0023124 Apr 2000 WO
0024332 May 2000 WO
0028554 May 2000 WO
0054689 Sep 2000 WO
0108578 Feb 2001 WO
0170114 Sep 2001 WO
0207786 Jan 2002 WO
0241786 May 2002 WO
03000308 Jan 2003 WO
2004045444 Jun 2004 WO
2005013832 Feb 2005 WO
2005089664 Sep 2005 WO
2006056739 Jun 2006 WO
2006097331 Sep 2006 WO
2006105353 Oct 2006 WO
2007069105 Jun 2007 WO
2008077081 Jun 2008 WO
Non-Patent Literature Citations (15)
Entry
Johnson & Johnson: New Minimally Invasive Breast Biopsy Device Receives Marketing Clearance in Canada; Aug. 6, 1999. From http://www.jnjgateway.com. 4 pages.
Johnson & Johnson: Mammotome Hand Held Receives FDA Marketing Clearance for Minimally Invasive Breast Biopises; Sep. 1, 1999. From From http://www.jnjgateway.com. 5 pages.
Liberman, Laura, et al. Percutaneous Removal of Malignant Mammographic Lesions at Stereotactic Vacuum-assisted Biopsy. From: The Departments of Radiology, Pathology, and Surgery. Memorial Sloan-Kettering Cancer Center. From the 1997 RSNA scientific assembly. vol. 206, No. 3. pp. 711-715.
Crook, et al. (Prostate Motion During Standard Radiotherapy As Assessed By Fiducial Markers, 1995, Radiotherapy and Oncology 37:35-42.).
Zmora, et al. (Tailoring the pore architecture in 3-D alginate scaffolds by controlling the freezing regime during fabrication, 2001, Elsevier Science Ltd.).
Madihally, et al. (Porous chitosan scaffolds for tissue engineering, 1998, Elsevier Science Ltd.).
Fajardo, Laurie, et al., “Placement of Endovascular Embolization Microcoils to Localize the Site of Breast Lesions Removed at Stereotactic Core Biopsy”, Radiology, Jan. 1998, pp. 275-278, vol. 206—No. 1.
H. J. Gent, M.D., et al., Stereotaxic Needle Localization and Cytological Diagnosis of Occult Breast Lesions, Annals of Surgery, Nov. 1986, pp. 580-584, vol. 204—No. 5.
Meuris, Bart, “Calcification of Aortic Wall Tissue in Prosthetic Heart Valves: Initiation, Influencing Factors and Strategies Towards Prevention”, Thesis, 2007, pp. 21-36, Leuven University Press; Leuven, Belgium.
Shah, et al. (Polyethylene Glycol as a Binder for Tablets, vol. 66, No. 11, Nov. 1977, Journal of Pharmaceutical Sciences).
Armstong, J.S., et al., “Differential marking of Excision Planes in Screened Breast lesions By Organically Coloured Gelatins”, Journal of Clinical Pathology, Jul. 1990, No. 43 (7) pp. 604-607, XP000971447 abstract; tables 1,2.
Fucci, V., et al., “Large Bowel Transit Times Using Radioopaque Markers in Normal Cats”, J. of Am. Animal Hospital Assn., Nov.-Dec. 1995 31 (6) 473-477.
Schindlbeck, N.E., et al., “Measurement of Colon Transit Time”, J. of Gastroenterology, No. 28, pp. 399-404, 1990.
Shiga, et al., Preparation of Poly(D, L-lactide) and Copoly(lactide-glycolide) Microspheres of Uniform Size, J. Pharm. Pharmacol. 1996 48:891-895.
Eiselt, P. et al, “Development of Technologies Aiding Large-Tissue Engineering”, Biotechnol. Prog., vol. 14, No. 1, pp. 134-140, 1998.
Related Publications (1)
Number Date Country
20180200019 A1 Jul 2018 US
Provisional Applications (1)
Number Date Country
60427048 Nov 2002 US
Divisions (1)
Number Date Country
Parent 15078847 Mar 2016 US
Child 15381717 US
Continuations (4)
Number Date Country
Parent 15381717 Dec 2016 US
Child 15853052 US
Parent 12850844 Aug 2010 US
Child 15078847 US
Parent 11275918 Feb 2006 US
Child 12850844 US
Parent 10710587 Jul 2004 US
Child 11275918 US
Continuation in Parts (1)
Number Date Country
Parent 10707044 Nov 2003 US
Child 10710587 US